Huntington National Bank’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6 Hold
1
﹤0.01% 4042
2026
Q1
$3 Hold
1
﹤0.01% 3986
2025
Q4
$4 Hold
1
﹤0.01% 3864
2025
Q3
$3 Hold
1
﹤0.01% 3926
2025
Q2
$3 Hold
1
﹤0.01% 3931
2025
Q1
$4 Hold
1
﹤0.01% 3907
2024
Q4
$2 Hold
1
﹤0.01% 3981
2024
Q3
$1 Hold
1
﹤0.01% 4017
2024
Q2
$2 Hold
1
﹤0.01% 3920
2024
Q1
$2 Hold
1
﹤0.01% 3791
2023
Q4
$2 Hold
1
﹤0.01% 3692
2023
Q3
$2 Hold
1
﹤0.01% 3668
2023
Q2
$1 Hold
1
﹤0.01% 3651
2023
Q1
$2 Hold
1
﹤0.01% 3486
2022
Q4
$2 Hold
1
﹤0.01% 3350
2022
Q3
$0 Hold
1
﹤0.01% 2074
2022
Q2
$0 Hold
1
﹤0.01% 2102
2022
Q1
$0 Hold
1
﹤0.01% 2090
2021
Q4
$0 Hold
1
﹤0.01% 2060
2021
Q3
$0 Hold
1
﹤0.01% 1819
2021
Q2
$0 Hold
1
﹤0.01% 1738
2021
Q1
$0 Hold
1
﹤0.01% 1636
2020
Q4
$0 Hold
1
﹤0.01% 1591
2020
Q3
$0 Hold
1
﹤0.01% 1545
2020
Q2
$0 Hold
1
﹤0.01% 1530
2020
Q1
$0 Hold
1
﹤0.01% 1578
2019
Q4
$0 Hold
1
﹤0.01% 1682
2019
Q3
$0 Hold
1
﹤0.01% 1554
2019
Q2
$0 Buy
+1
New +$6 ﹤0.01% 1602
2019
Q1
Sell
-1
Closed 1585
2018
Q4
$0 Hold
1
﹤0.01% 1677
2018
Q3
$0 Buy
+1
New +$6 ﹤0.01% 1696

Other funds holding CPIX

Huntington National Bank's CPIX Position: Q2 2026 in Review

Huntington National Bank held its Cumberland Pharmaceuticals (CPIX) position steady in Q2 2026 at 1 share worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #4042.

Huntington National Bank first reported a position in CPIX in Q3 2018 and has held it in 31 quarters since. 23 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Huntington National Bank held 1 share of Cumberland Pharmaceuticals worth $6 as of Q2 2026.
  • Huntington National Bank left its Cumberland Pharmaceuticals share count unchanged in Q2 2026.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #4042 holding.
  • Huntington National Bank first reported a position in Cumberland Pharmaceuticals in Q3 2018 and has held it in 31 quarters since.
  • 23 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.